首页 | 本学科首页   官方微博 | 高级检索  
     


Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
Authors:Bertram Pitt  Stefan D. Anker  Michael Böhm  Mihai Gheorghiade  Lars Køber  Henry Krum  Aldo P. Maggioni  Piotr Ponikowski  Adriaan A. Voors  Faiez Zannad  Christina Nowack  So‐Young Kim  Alexander Pieper  Nina Kimmeskamp‐Kirschbaum  Gerasimos Filippatos
Affiliation:1. University of Michigan Medical School, Ann Arbor, MI, USA;2. Department of Innovative Clinical Trials, University Medical Centre G?ttingen, G?ttingen, Germany;3. Universit?tskliniken des Saarlandes, Homburg, Germany;4. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;5. Heart Centre, Rigshospitalet, University of Copenhagen, Denmark;6. Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia;7. Research Centre of the Italian Association of Hospital Cardiologists, Florence, Italy;8. Medical University, Clinical Military Hospital, Wroc?aw, Poland;9. University Medical Centre Groningen, Groningen, Netherlands;10. CHU Department of Cardiology, Université de Lorraine, Nancy, France;11. Global Clinical Development, Bayer HealthCare AG, Leverkusen, Germany;12. M.A.R.C.O. GmbH & Co. KG, Düsseldorf, Germany;13. Global Research & Development Statistics, Bayer HealthCare AG, Leverkusen, Germany;14. Department of Cardiology, Attikon University Hospital, Athens, Greece
Abstract:
Keywords:Antagonist  Chronic kidney disease  Heart failure  Mineralocorticoid receptor  Type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号